Corrected serum cystatin C-effects of thyroid dysfunctions on serum cystatin C in chronic kidney diseased patients
Abstract
Objective: To assess serum cystatin C (Cys C) and creatinine concentrations and glomerular filtration rate (GFR) in thyroid dysfunction and to determine corrected value of cystatin C in chronic kidney disease (CKD) patients with thyroid dysfunction.
Study design: Cross sectional study.
Place & study duration: Department of Chemical Pathology & Endocrinology, Armed Forces Institute of Pathology, July 2015 to January 2016.
Patients and Methods: Seventy five patients; both male and female patients of CKD with 24 hours creatinine clearance less than 60 ml/min were included. Their serum samples were analyzed for serum TSH, serum T4, serum T3 on Advia XP by chemiluminence methods and serum cystatin C on Nephstar by Nephelometry. eGFR is calculated by Modified MDRD’s equation and eGFR EPI equation by serum creatinine which was analyzed on Advia 1800® by Siemens.
Result: Out of 75 subjects, 42 (56%) were male and 33 (44%) were female. Median aged was 42.7 years (IQR: 37 years). For other quantitative variables mean±SD along with independent t- statistics were, serum cystatin C (1.27 ± 1.02 )mg/L, Serum TSH (2.95± 8.6) mIU/L Serum FT4 (13.4±3.6) pmol/L, Serum T3 (1.7±0.4) nmol/L, 24hours Creatinine Clearance (43.6± 14.9)ml/min, MDRD eGFR (59.9 ± 24.9)ml/min and CKD-EPI eGFR (61.3± 25.0)ml/min. Cystatin C had negative correlation with serum TSH (r= -0.037,p=0.750), positive correlation with T4 (R= 0.045 ,p=0.701) and T3 (r= 0.064 ,p=.585) .Cystatin C had negative correlation with GFR CrCL (r= -0.074,p=0.526), GFR MDRD (r=-0.932,p<0.05), eGFR EPI( r=-0.100,p<0.392) while GFR CrCl had significant correlation with both GFR MDRD and eGFR EPI with correlation coefficient 0.425 and 0.434 (p<0.000).
Conclusion: Corrected cystatin C calculated by adding factor of 0.04 in measured cystatin C in patients of CKD with hypothyroidism and subtracting this factor from measured cystatin C in CKD patients with hyperthyroidism improves diagnostic yield.
Key Words: Cystatin C, CKD (chronic kidney disease), Thyroid dysfunctions.Â
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2016 Safia Fatima, Aamir Ijaz, Umair Siddiqui Siddiqui, Sohail Sabir, Tariq Rafi, Muhammad Ayyub

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
